Gregory A. Maglinte

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

Michael J. Overman, Ray McDermott, Joseph L. Leach et al. · The Lancet Oncology · 2017 · 2.7K citations · Full text

Checkmate 142, Medicine, Colorectal Cancer +8

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study ( <scp>IBMS‐II</scp> )

Andrew Blumenfeld, Lisa Bloudek, Werner J. Becker et al. · Headache The Journal of Head and Face Pain · 2013 · 370 citations

Validating Migraine‐Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine

Christine L. Bagley, Regina Rendas‐Baum, Gregory A. Maglinte et al. · Headache The Journal of Head and Face Pain · 2011 · 157 citations

US general population norms for telephone administration of the SF-36v2

Gregory A. Maglinte, Ron D. Hays, Robert M. Kaplan · Journal of Clinical Epidemiology · 2012 · 136 citations · Full text

Public Policy, Communication, Telephone Administration +1

The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients

Regina Rendas‐Baum, Lisa Bloudek, Gregory A. Maglinte et al. · Quality of Life Research · 2012 · 115 citations · Full text